An In-Depth Look at Bicycle Therapeutics Plc ADR’s (BCYC) Stock Performance
In the past week, BCYC stock has gone down by -27.42%, with a monthly decline of -30.52% and a quarterly plunge of -37.85%. The volatility
In the past week, BCYC stock has gone down by -27.42%, with a monthly decline of -30.52% and a quarterly plunge of -37.85%. The volatility
The stock of Bicycle Therapeutics Plc ADR (NASDAQ: BCYC) has decreased by -32.57 when compared to last closing price of 20.11.Despite this, the company has
The stock has a 36-month beta value of 0.88. Opinions on the stock are mixed, with 7 analysts rating it as a “buy,” 5 as
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.